Tag: european union
Softbank, Demeter and Coparion invest $3M into Plan A’s B2B carbon monitoring and ESG platform
Plan A, a Berlin-based automated SaaS B2B startup, has raised $3 million for its platform that lets companies measure, monitor, reduce and report their environmental footprint thus improving their ESG ratings. French VC Demeter led the round, with German VC Coparion and Softbank joined the round as a strategic investor.…
Read More
China launched its national carbon trading market yesterday
Yesterday, China flipped the switch on a nationwide carbon trading market, in what could be one of the most significant steps taken to reduce greenhouse gas emissions in 2021 — if the markets can work effectively. China is the world’s largest emitter of greenhouse gases and its share of the…
Read More
This Week in Apps: TikTok viral hit breaks Spotify records, inauguration boosts news app installs, judge rules against Parler
Welcome back to This Week in Apps, the weekly TechCrunch series that recaps the latest in mobile OS news, mobile applications and the overall app economy. The app industry is as hot as ever, with a record 218 billion downloads and $143 billion in global consumer spend in 2020. Consumers last year also spent 3.5 trillion minutes…
Read More
EU fines Valve and major game publishers for geo-blocking titles
Nearly two years after filing charges, the European Union is demanding remedies from Valve and other publishers for geo-blocking games. The European Commission has fined Valve, Bandai Namco, Capcom, Focus Home, Koch Media and Bethesda owner ZeniMax a… Source
Read More
Enter new markets and embrace a distributed workforce to grow during a pandemic
Sarah Cole Contributor Sarah Cole is a senior associate in Taylor Wessing‘s Silicon Valley office. She advises mostly North American technology and life sciences companies on their investments into the UK and Europe, including on European launches, cross-border M&A, venture capital and other growth company investment work. Mark Barron Contributor…
Read More
Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from contracting COVID-19 across 196 confirmed cases from among 30,000 participants in the study. Moderna also found that it was 100%…
Read More